Midacip 1.25 Nasal Spray
Prescription Required
Product introduction
Midacip 1.25 Nasal Spray is used as a sedative or for conscious sedation before diagnostic or therapeutic procedures. It relieves anxiety and muscle tensions, thus making the person comfortable before investigations or minor surgical or dental procedures.
Midacip 1.25 Nasal Spray is used to reduce anxiety, epilepsy and promote sleep.
Midacip 1.25 Nasal Spray is used to reduce anxiety, epilepsy and promote sleep.
Uses of Midacip Nasal Spray
Benefits of Midacip Nasal Spray
In Conscious sedation during diagnostic or therapeutic procedures
Midacip 1.25 Nasal Spray may be used before medical procedures and surgery to cause drowsiness and relieve anxiety. This helps to carry out surgical procedures or diagnostic procedures without causing pain or discomfort to the patient.
Side effects of Midacip Nasal Spray
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Midacip
- Sleepiness
- Headache
- Nasal discomfort
- Throat irritation
- Runny nose
How to use Midacip Nasal Spray
Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Insert the bottle tip into one nostril and close the other nostril. Direct the spray towards the sides of your nostril, away from the cartilage dividing the two sides of your nose. As you spray, breath gently and keep the head upright. Repeat the same process for the other nostrils.
How Midacip Nasal Spray works
Midacip 1.25 Nasal Spray is a benzodiazepine (BZD). It is rapidly absorbed into the bloodstream through the inner lining of the nose. Once absorbed, it works by increasing the action of GABA, a chemical messenger that suppresses the abnormal and excessive activity of the nerve cells in the brain. This helps the patient to recover from a seizure faster.
Safety advice
Alcohol
No interaction found/established
Pregnancy
CONSULT YOUR DOCTOR
Midacip 1.25 Nasal Spray is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Midacip 1.25 Nasal Spray is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Midacip 1.25 Nasal Spray should be used for short periods and sleepiness of the baby should be watched. The withdrawal of Midacip 1.25 Nasal Spray should be gradual.
Midacip 1.25 Nasal Spray should be used for short periods and sleepiness of the baby should be watched. The withdrawal of Midacip 1.25 Nasal Spray should be gradual.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Midacip 1.25 Nasal Spray
₹528.0/Nasal Spray
Insed Plus Atomiser
Samarth Life Sciences Pvt Ltd
₹199/nasal spray
62% cheaper
Medistat 1.25 Nasal Spray
Alteus Biogenics Pvt Ltd
₹580.8/nasal spray
10% costlier
Midazom 1.25 Nasal Spray
Mindneuro Pharma
₹540/nasal spray
2% costlier
Quick tips
- The addiction / habit-forming potential of this medicine is very high. Take it only as per the dose and duration advised by your doctor
- It may cause dizziness. Do not drive or do anything that requires mental focus until you know how this medicine affects you.
- Avoid consuming alcohol as it may increase dizziness and drowsiness.
- Inform your doctor if you are pregnant, planning to conceive or breastfeeding.
- Do not stop taking medication suddenly without talking to your doctor as that may lead to nausea, anxiety, agitation, flu-like symptoms, sweating, tremor, and confusion.
Fact Box
Chemical Class
Benzodiazepines Derivative
Habit Forming
Yes
Therapeutic Class
NEURO CNS
Action Class
Benzodiazepines
Patient concerns
User feedback
Patients taking Midacip 1.25 Nasal Spray
Once A Day
92%
Twice A Day
5%
Four Times A *
2%
*Four Times A Day
FAQs
Is Midacip 1.25 Nasal Spray safe?
Midacip 1.25 Nasal Spray is safe if used at prescribed doses for the prescribed duration as advised by your doctor
Is Midacip 1.25 Nasal Spray a controlled substance?
Yes, Midacip 1.25 Nasal Spray is a controlled substance
Is Midacip 1.25 Nasal Spray a sedative?
Yes, Midacip 1.25 Nasal Spray a sedative medication used before and during diagnostic or surgical procedures either in combination with or without local anesthesia
Is Midacip 1.25 Nasal Spray a benzodiazepine?
Yes, Midacip 1.25 Nasal Spray belongs to benzodiazepine class of sedative medication
Does Midacip 1.25 Nasal Spray have analgesic properties?
No, Midacip 1.25 Nasal Spray does not have any analgesic properties. It is used as a central nervous system depressant that slows brain activity, causes relaxation and induces sleep (anesthetic)
Does Midacip 1.25 Nasal Spray cause retrograde amnesia?
Yes, Midacip 1.25 Nasal Spray causes retrograde amnesia (short term loss of memory)
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Midazolam. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 431-33.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 914-15.
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 20 Mar. 2019] (online) Available from:
- CiplaMed. Midazolam. [Accessed 25 Mar 2019] (online) Available from:
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present